Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcar...

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Beukinga, Ingrid, Blairon, Laurent
Publicado 2021

The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another

por Blairon, Laurent, Cupaiolo, Roberto, Piteüs, Sébastien, Beukinga, Ingrid, Tré-Hardy, Marie
Publicado 2021

Enterococcus thailandicus, an unusual pathogen in humans encountered in an intra-abdominal infection

por Mbouche, Patricia, Blairon, Laurent, Cupaiolo, Roberto, Zaouak, Yasmine, Hainaux, Bernard, Beukinga, Ingrid, Tré-Hardy, Marie
Publicado 2023

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

por Tré-Hardy, Marie, Cupaiolo, Roberto, Papleux, Emmanuelle, Wilmet, Alain, Horeanga, Alexandra, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Beukinga, Ingrid, Vekemans, Marc, Blairon, Laurent
Publicado 2021

Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2021

Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Coman-Vlagea, Nicoleta, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2022